Discover 815 paid clinical trials in Jacksonville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Jacksonville currently offers many active clinical trials, particularly in the areas of diabetes, cardiovascular health, and chronic pain management. With opportunities for both healthy volunteers seeking paid studies, as well as those looking for trials tailored to specific conditions, these trials offer participants access to cutting-edge treatments while advancing healthcare.
Filter
2
Filter results
Results: 815
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Jacksonville FL, Gainesville FL, Orlando FL, Tampa FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: Jacksonville FL, Tampa FL, Atlanta GA, Miami FL,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase2, Recruiting
PROspect Registry :Post Market Clinical Follow-up Study
for
Breast Surgery
Location: Jacksonville FL, Boston MA
Sponsor: Stryker Endoscopy
Sex: All
Age: 18+
Code: NCT07631468
Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Jacksonville FL, Atlanta GA, Miami Beach FL, Miami FL,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Jacksonville FL, Savannah GA, Fort Myers FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Jacksonville FL, Fort Myers FL, Atlanta GA, Weston FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Jacksonville FL, Orange City FL, Charleston SC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
for
Melanoma
Location: Jacksonville FL, Camden NJ, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04594187
Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Jacksonville FL, Savannah GA, Lakeland FL, Tampa FL,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles